The Use of Intranasal Ketoralac for Pain Management (Sprix)

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Postoperative Pain Management, Urolithiasis

In brief

Despite an overall reduction in the perioperative complication rate, post operative pain management after ureteroscopic removal of stones (URS) remains a major factor delaying discharge of patients. The investigators hypothesize that perioperative usage of intranasal ketorolac will provide a reduction in post operative opioid requirements, better post operative pain control, higher anesthesia satisfaction and faster recovery.

Key facts

Study ID
NCT01736358
Run by
Montefiore Medical Center
People needed
50
Starts
2012-10-01
Expected to finish
2014-06-01
Last updated by the study team
2020-02-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.